Author(s): Bassam S. Bin-Abbas
Detemir (levemir™) insulin is a recently approved, long acting insulin analog that is increasingly being used in children and adults with diabetes. Ten Saudi children with type 1 diabetes mellitus were selected and started on determir-based basal-bolus insulin therapy. This study showed that basal-bolus insulin regimen is effective in improving the metabolic control in type 1 diabetic Saudi children. The results of this local experiment are encouraging to implement this mode of intensive insulin therapy in all candidate diabetic Saudi children